BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9452277)

  • 1. Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma.
    Demir I; Akan OY; Bilgir F; Yilmaz I; Bozkaya G; Bilgir O
    Ir J Med Sci; 2024 Jun; 193(3):1201-1207. PubMed ID: 38270775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Block-Removed Immunoglobulin Technology to enhance rituximab effector function by counteracting CA125-mediated immunosuppression.
    Grasso L; Kline JB; Nicolaides NC
    Oncol Lett; 2022 Jan; 23(1):2. PubMed ID: 34820001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary non-Hodgkin's lymphoma of the vagina (PNHLV): a gynaecologist's enigma!
    Bhagat N; Kalkur P; Kalkur S
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31061180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Role of Tumor Marker CA-125 in B-Cell non-Hodgkin's Lymphoma.
    Memar B; Aledavood A; Shahidsales S; Ahadi M; Farzadnia M; Raziee HR; Noori S; Tayebi-Meybodi N; Amouian S; Mohtashami S
    Iran J Cancer Prev; 2015; 8(1):42-6. PubMed ID: 25821570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NonHodgkin's Lymphoma with Peritoneal Localization.
    Curakova E; Genadieva-Dimitrova M; Misevski J; Caloska-Ivanova V; Andreevski V; Todorovska B; Isahi U; Trajkovska M; Misevska P; Joksimovic N; Genadieva-Stavric S; Antovic S; Jankulovski N
    Case Rep Gastrointest Med; 2014; 2014():723473. PubMed ID: 24711934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer.
    Anand R; Markman M
    Case Rep Oncol; 2011 Mar; 4(1):172-4. PubMed ID: 21526135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-Hodgkin's lymphomas. I. Clinico-biological features of 307 cases].
    García Zueco JC; Delgado MP; Giraldo MP; Perella M; Torres M; Valero MI; Ríos MJ; García Julián G; Giralt M
    Sangre (Barc); 1992 Oct; 37(5):331-6. PubMed ID: 1293771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
    Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
    Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.
    Bairey O; Blickstein D; Stark P; Prokocimer M; Nativ HM; Kirgner I; Shaklai M
    Leuk Lymphoma; 2003 Oct; 44(10):1733-8. PubMed ID: 14692526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
    Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
    Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA 125 levels in children with non-Hodgkin's lymphoma.
    Kutluk T; Varan A; Erbaş B; Büyükpamukçu M
    Pediatr Hematol Oncol; 1999; 16(4):311-9. PubMed ID: 10407867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.